Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life
Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine
Pneumococcal conjugate vaccination: clinical impact, reduced-dose schedules and immunologic responses
Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of streptococcus pneumoniae
The PIM study: Immunogenicity of the 13-valent polysaccharide pneumococcal conjugate vaccine : Comparison of current schedule with alternative and reduced immunisation schedules
Rijksinstituut voor Volksgezondheid
Rijksinstituut voor Volksgezondheid